本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

13.44
+0.60004.67%
盤後13.660.2200+1.64%18:14 EST
成交量:144.28萬
成交額:1,960.09萬
市值:15.05億
市盈率:-8.36
高:13.97
開:12.84
低:12.80
收:12.84
52周最高:32.06
52周最低:10.70
股本:1.12億
流通股本:9,414.79萬
量比:0.75
換手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-1.6074
每股收益(LYR):-1.5638
淨資產收益率:-50.60%
總資產收益率:-8.30%
市淨率:4.41
市盈率(LYR):-8.59

資料載入中...

2025/12/01

重要事件披露

Form 8-K - Current report
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report